Showing results (481-490 of 528) with videos related to
Sort By:
Pageof 53
Cancer Immunology, Immunotherapy : CII|July 12, 2025
Real-world effectiveness and safety of first-line chemoimmunotherapy combinations in metastatic non-small cell lung cancer with programmed death ligand-1 < 50%: results from an Italian observational studyAlessandro Inno, Antonello Veccia, Ettore D'Argento, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 18, 2022
Elacestrant (oral selective estrogen receptor degrader) Versus Standard Endocrine Therapy for Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Results From the Randomized Phase III EMERALD TrialFrancois-Clement Bidard, Virginia G Kaklamani, Patrick Neven, et al.Journal of Clinical Medicine|February 13, 2026
Chemoimmunotherapy Combinations in Elderly Patients with Metastatic Non-Small Cell Lung Cancer and PD-L1 Expression < 50%: Results from an Italian Real-World StudyAntonello Veccia, Ettore D'Argento, Floriana Morgillo, et al.Lung Cancer (Amsterdam, Netherlands)|May 18, 2025
A prospective study on clinicians' attitudes and survival outcomes for patients with advanced NSCLC and poor performance status in the immunotherapy era: PICASO (GOIRC-04-2020)Francesco Facchinetti, Andrea Camerini, Chiara Bennati, et al.Lung Cancer (Amsterdam, Netherlands)|December 29, 2023
Sotorasib in KRASp.G12C mutated advanced NSCLC: Real-world data from the Italian expanded access programFrancesco Passiglia, Maria Lucia Reale, Giuseppe Lo Russo, et al.Plos One|September 5, 2015
The Promher Study: An Observational Italian Study on Adjuvant Therapy for HER2-Positive, pT1a-b pN0 Breast CancerStefania Gori, Alessandro Inno, Elena Fiorio, et al.Cancers|October 14, 2022
Combined Large Cell Neuroendocrine Carcinomas of the Lung: Integrative Molecular Analysis Identifies Subtypes with Potential Therapeutic ImplicationsMichele Simbolo, Giovanni Centonze, Luca Giudice, et al.Cancer Treatment Reviews|October 27, 2018
Best practices for the management of thymic epithelial tumors: A position paper by the Italian collaborative group for ThYmic MalignanciEs (TYME)Martina Imbimbo, Margaret Ottaviano, Milena Vitali, et al.BMC Cancer|June 13, 2023
Lung cancer multi-omics digital human avatars for integrating precision medicine into clinical practice: the LANTERN studyFilippo Lococo, Luca Boldrini, Charles-Davies Diepriye, et al.European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|April 25, 2024
Robotic thymectomy in thymic tumours: a multicentre, nation-wide studyGiovanni Maria Comacchio, Marco Schiavon, Carmelina Cristina Zirafa, et al.Pageof 53